Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Evogene Ltd. Report Publication Announcement 2020

May 5, 2020

6785_rns_2020-05-05_517571b1-0c47-468c-b68f-7788e4101fe4.htm

Report Publication Announcement

Open in viewer

Opens in your device viewer

CEO Letter to Shareholders false

����� ��"� 2 380
EVOGENE LTD
Corporation no: 512838723 11441
- - -
Israel Securities Authority Tel Aviv Stock Exchange C002 ( Public ) Reported via MAGNA: 05/05/2020
www.isa.gov.il www.tase.co.il Reference: 2020-02-039784 Time of broadcast: 11:52 11:45:37

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report onCEO Letter to Shareholders

CEO_Letter_to_Shareholders_2020_ISA.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
- - -
Stock Exchange/Market: -1 Date of revision of form structure: 22/04/2020
Address: Gad Feinstein St 13, P.O.B 2100 , Rehovot 76121   , Tel: 08-9311900 , Fax: 08-9466724
E-mail address: [email protected]   Company site: www.evogene.com
Previous names of reporting entity:
Name of the Signatory: Bartov Pinto Amitai Position of Signatory in the reporting corporation: Attorney/Legal Counsel Name of Employer Company:
Address: Gad Feinstein 13 , Rehovot 7612002 Telephone: 08-9311962 Facsimile: 08-9466724 E-mail: [email protected] 1